Literature DB >> 17943189

Retinoic acid increases aquaporin 3 expression in normal human skin.

Gaelle Bellemère1, Otto Von Stetten, Thierry Oddos.   

Abstract

We have investigated the effects of all-trans retinoic acid (ATRA) on aquaporin 3 (AQP3) expression and function both in vitro and ex vivo. ATRA treatment provoked a rapid accumulation of AQP3 transcripts in cultured normal human epidermal keratinocytes (NHEK). This increase was still observed 24 hours after application of ATRA. The induction of AQP3 gene was accompanied by an augmentation of immunoreactivity. Using a selective agonist, we demonstrated that the effect of ATRA was predominantly mediated by retinoic acid receptor subtype gamma (RARgamma). Incubation of NHEK in ATRA for 24, 48, and 72 hours stimulated glycerol influx, suggesting that the increase in AQP3 gene and protein expression was followed by an enhancement of biological activity. Topical application of ATRA for 24 hours on skin explants induced significant epidermal expression of AQP3 and strong immunoreactivity in the epidermal basal layers. Collectively, the present results show that ATRA increased AQP3 expression and enhanced biological activity in human skin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943189     DOI: 10.1038/sj.jid.5701047

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  The relationship of diet and acne: A review.

Authors:  Apostolos Pappas
Journal:  Dermatoendocrinol       Date:  2009-09

2.  Aquaporin-3 re-expression induces differentiation in a phospholipase D2-dependent manner in aquaporin-3-knockout mouse keratinocytes.

Authors:  Vivek Choudhary; Lawrence O Olala; Haixia Qin; Inas Helwa; Zhi-Qiang Pan; Ying-Ying Tsai; Michael A Frohman; Ismail Kaddour-Djebbar; Wendy B Bollag
Journal:  J Invest Dermatol       Date:  2014-09-18       Impact factor: 8.551

3.  PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis.

Authors:  Yan J Jiang; Peggy Kim; Yang F Lu; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2011-04-04       Impact factor: 3.960

4.  Epidermal aquaporin-3 is increased in the cutaneous burn wound.

Authors:  R Sebastian; E Chau; P Fillmore; J Matthews; L A Price; V Sidhaye; S M Milner
Journal:  Burns       Date:  2015-01-18       Impact factor: 2.744

5.  Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression.

Authors:  Inas Helwa; Vivek Choudhary; Xunsheng Chen; Ismail Kaddour-Djebbar; Wendy B Bollag
Journal:  J Pharmacol Exp Ther       Date:  2017-05-17       Impact factor: 4.030

6.  The expression of differentiation markers in aquaporin-3 deficient epidermis.

Authors:  Mariko Hara-Chikuma; Kenzo Takahashi; Shunsuke Chikuma; A S Verkman; Yoshiki Miyachi
Journal:  Arch Dermatol Res       Date:  2009-01-31       Impact factor: 3.017

7.  Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics.

Authors:  Marco A Mendoza-Parra; Mannu Walia; Martial Sankar; Hinrich Gronemeyer
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

8.  An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy.

Authors:  Eric Dupont; Michel Journet; Marie-Laure Oula; Juan Gomez; Claude Léveillé; Estelle Loing; Diane Bilodeau
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-02-20

9.  Aquagenic keratoderma. Two new case reports and a new hypothesis.

Authors:  Georgi Tchernev; Kristina Semkova; José Carlos Cardoso; J Julian Ananiev; Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2014-01

10.  Changes in transepidermal water loss and skin hydration according to expression of aquaporin-3 in psoriasis.

Authors:  Young Lee; Young-Jin Je; Sang-Sin Lee; Zheng Jun Li; Dae-Kyoung Choi; Yoo-Bin Kwon; Kyung-Cheol Sohn; Myung Im; Young Joon Seo; Jeung Hoon Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.